期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 59, 期 7, 页码 3034-3045出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.5b01657
关键词
-
The discovery of a highly potent and selective small molecule inhibitor 9 for in vitro target validation of MNK1/2 kinases is described. The aminopyrazine benzimidazole series was derived from an HTS hit and optimized by utilization of a docking model, conformation analysis, and binding pocket comparison against antitargets.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据